Author Archive | admin

Withdrawal case studies needed by Daily Mail

The Daily Mail Good Health section is planning to run another article on the widespread problem of drug dependency involving prescription medicines such as opioids, gabapentinoids, benzodiazepines, Z-drugs and antidepressants. The article will examine the scale of the problem and the amount spent on inappropriate prescribing. To help to tell the story and illustrate the […]

Continue Reading 4

Guest blog: Really depressed people need antidepressants! Do they?

Martin Plöderl, PhD Clinical Psychologist, Psychotherapist, Salzburg, Austria Despite decades of research and more than 100,000 patients in clinical trials, it is still debated if the efficacy of antidepressants is clinically meaningful and if prescriptions are justified, given the small benefits and the harms (Jakobsen et al., 2019; Munkholm et al., 2019). Nonetheless, there is […]

Continue Reading 1
kinderman3

Prof Peter Kinderman: Should ECT be judged by the standards of homeopathy?

This blog was originally published on 7th September 2020 on the Psychology Today website as: https://www.psychologytoday.com/us/blog/our-turbulent-minds/202009/should-ect-be-judged-the-standards-homeopathy —o— Extraordinarily, we now live in a world in which the best evidence [https://www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/ect] that the Royal College of Psychiatrists has been able to muster for the real-world effectiveness of ECT exactly parallels the claims for homeopathy.  ECT is defended […]

Continue Reading 17
james-davies2 200x262

Major milestone: Royal College releases new guidance on stopping antidepressants

Today I welcome the new patient information leaflet, entitled ‘Stopping Antidepressants’, published by the Royal College of Psychiatrists.  The leaflet distills many years of work by researchers, campaigners and the prescribed harm community, which has jointly challenged previous understandings of antidepressant withdrawal as being a relatively benign experience for most people.  Instead, the leaflet now […]

Continue Reading 38

Guest blog: Call for an independent review into the practice of ECT

By Lucy Johnstone and Sue Cunliffe Electroconvulsive therapy, or ECT, is still given to about 2,100 -2,700 people a year in England, about half of whom have not consented to it. This blog reports on a campaign for an independent review of this highly controversial procedure, and provides links to relevant articles. There will be […]

Continue Reading 4
Richard_Bentall2

Guest blog by Richard P. Bentall: ECT is a classic failure of evidence-based medicine

A commentary on Read, J., Kirsch, I., & McGrath, L. (2020). Electroconvulsive therapy for depression: A review of the quality of ECT versus sham ECT trials and meta-analyses. Ethical Human Psychology and Psychiatry, 21, 64-103.  Richard P. Bentall, Professor of Clinical Psychology, University of Sheffield In a discipline to which controversy is no stranger, there are […]

Continue Reading 8

Update: APPG for Prescribed Drug Dependence

The Council for Evidence-based Psychiatry, secretariat of the APPG for Prescribed Drug Dependence until the end of the last parliament, wanted to provide a short update on the recent activities of the APPG.   Following the publication of the PHE Prescribed Medicines Review in September last year, the APPG worked hard to secure a commitment from the […]

Continue Reading 4

Guest blog: NICE depression guideline – cautious optimism?

NICE depression guideline: cautious optimism? Susan McPherson, University of Essex This commentary is a revised and updated version of a Rapid Response letter to the BMJ in September 2019 posted prior to NICE’s decision letter of December 2019: https://www.bmj.com/content/365/bmj.l2356/rr-0 In a joint stakeholder position statement concerning the NICE 2018 draft depression guideline, six methodological issues were […]

Continue Reading 1

Blog: Are our regulatory bodies prioritising drug company interests over public safety?

The Disturbing Case of the Street Drug Ketamine The UK’s Medicines & Healthcare Products Regulatory Agency (MHRA) is refusing to respond to the concerns of psychiatrists, parliamentarians, patients and other experts about the impending licensing of the street drug ketamine as a treatment for depression. In March this year, the USA’s Food and Drug Administration […]

Continue Reading 13

BBC is looking for people willing to appear in documentary on antidepressant withdrawal

The BBC is producing a documentary about the long-term side effects and withdrawal effects of antidepressant medication. They are looking to speak to individuals who have decided to come off their medication and would be open to allowing us to follow their journey throughout this process, alongside the reporter of the film who will be […]

Continue Reading 68

Powered by WordPress. Designed by WooThemes